PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed
{{output}}
Poly(ADP-ribose) polymerase (PARP) inhibitors have proven their efficacy for treating tumors defective in homologous recombination via synthetic lethality. In response to DNA breaks, PARP1 is the primary ADP-ribosylation writer, modifying itself (auto-modifica... ...
